Immunization standards

Influenza vaccine (seasonal) - inactivated (10 dose vial)

Vaccine Trade Name: Vaxigrip

Vaccine Type: Seasonal Influenza, split virion, inactivated

Manufacturer: Sanofi Pasteur

Country of Manufacture: France

Date of prequalification: 30 June 2011

NRA of Record: ANSM

Product Description

Pharmaceutical form: liquid

Presentation: 10 dose vial

Route of administration: intramuscular or deep subcutaneous

Vaccine Vial Monitor: Type 7

Shelf life: 12 months at 2 - 8°C

Secondary Packaging: carton of 10 vials

Cold Chain volume per dose (cm3): 2.38

Preservative: Thiomersal, 2 mcg/dose.

Handling of opened multi-dose vials: WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.

Remarks

Multi dose vaccines have considerable advantages in developing country immunization programmes, especially in campaign settings, as they are economical, occupy less space in the cold chain freeing free storage places for other important vaccines, and in many settings, preferable from the administration view point as well. These advantages, in the context of routine immunization, may become disadvantages due to the potential for high wastage rates. This vial presentation contains 10 doses which makes it prone to such wastage. Therefore the vaccine is more suitable for campaign settings, and users must weigh the significance of potentially high wastage in the context of routine vaccination programmes if they choose to use this vaccine brand.

Share

Last update:

22 August 2013 17:41 CEST